| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/15/2004 | WO2004005339A2 Cationic linear peptides having antibacterial and/or antifungal properties |
| 01/15/2004 | WO2004005329A1 Plant peptide with antimicrobial activity |
| 01/15/2004 | WO2004005313A2 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 01/15/2004 | WO2004005311A1 Bafilomycin-like metabolite from a novel micromonospora species |
| 01/15/2004 | WO2004005309A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 01/15/2004 | WO2004005298A1 Derivatives of rifabutine useful as antimicrobial agents |
| 01/15/2004 | WO2004005293A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 01/15/2004 | WO2004005292A1 Novel antibiotics against vibrio anguillarum and the applications thereof in cultures of fish, crustaceans, molluscs and other aquaculture activities |
| 01/15/2004 | WO2004005286A2 Viral inhibitors |
| 01/15/2004 | WO2004005277A1 Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 01/15/2004 | WO2004005276A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 01/15/2004 | WO2004005264A2 Imidazole compounds for the treatment of hepatitis c virus infections |
| 01/15/2004 | WO2004005258A1 Di-aryl-substituted-ethane pyridone pde4 inhibitors |
| 01/15/2004 | WO2004004771A1 Immunopotentiating compositions |
| 01/15/2004 | WO2004004764A1 Composition against white spot disease |
| 01/15/2004 | WO2004004760A1 Vaccine for feline infectious peritonitis |
| 01/15/2004 | WO2004004758A1 Method to enhance an immune response of nucleic acid vaccination |
| 01/15/2004 | WO2004004749A1 Proteaseome inhibitors for the treatment of herpesviridae infected individuals |
| 01/15/2004 | WO2004004737A1 Cephalosporin preparation for oral use |
| 01/15/2004 | WO2004004728A1 Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis |
| 01/15/2004 | WO2004004722A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | WO2004004720A1 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 01/15/2004 | WO2004004712A1 Methods of treating microbial infections in humans and animals |
| 01/15/2004 | WO2004004703A1 m-PHENYLENEDIAMINE DERIVATIVE |
| 01/15/2004 | WO2004004702A2 Method to inhibit ischemia and reperfusion injury |
| 01/15/2004 | WO2004004700A1 Methods for the treatment of sinusitis |
| 01/15/2004 | WO2004004698A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | WO2004004683A1 Solid dispersions comprising two different polymer matrixes |
| 01/15/2004 | WO2004004653A2 Methods for treating psychosis associated with interferon-alpha therapy |
| 01/15/2004 | WO2004004646A2 O-derivatized nocathiacin derivatives |
| 01/15/2004 | WO2004004633A2 Use of tnfalpha antibodies and another drug |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | WO2003089434A3 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF |
| 01/15/2004 | WO2003084936A8 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 01/15/2004 | WO2003082216A3 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/15/2004 | WO2003080794A3 Inhibition of rna function by delivery of inhibitors to animal cells |
| 01/15/2004 | WO2003080118A3 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 01/15/2004 | WO2003079969A3 Compositions and methods for treating and preventing necrosis |
| 01/15/2004 | WO2003070905A3 Electroporation methods for introducing bioactive agents into cells |
| 01/15/2004 | WO2003059260A3 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 01/15/2004 | WO2003057148A3 Use of biomolecular targets in the treatment and visualization of tumors |
| 01/15/2004 | WO2003019146A3 High throughput screening assays using fatty acid synthetic enzymes |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002096866A3 Thiolalkyl benzoic acid derivatives |
| 01/15/2004 | WO2002080966A8 Method for producing a vaccine containing autologous antibodies |
| 01/15/2004 | WO2002060935A8 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/15/2004 | WO2002055025A3 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/15/2004 | WO2002015896A3 Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms |
| 01/15/2004 | US20040010143 Viricides |
| 01/15/2004 | US20040010141 Antiinflammatory agents; anticancer agents; rheumatic disorders; cardiovascular disorders |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010125 Human immunodeficiency viral glycoprotein (HIV) for diagnosis, prevention and treatment of viral infection; genetic vaccines |
| 01/15/2004 | US20040010030 Novel anti-infectives |
| 01/15/2004 | US20040010029 Also benzothiophene derivatives; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and infections; modulating T helper cells, Th1/ Th2, and inhibiting the transcription of IL-4 |
| 01/15/2004 | US20040010027 Tumor angiogenesis and metastasis inhibition. |
| 01/15/2004 | US20040010023 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010010 Melanocortin receptor ligands |
| 01/15/2004 | US20040010008 Piperidine derivatives useful as CCR5 antagonists |
| 01/15/2004 | US20040010007 Also thio, sulfoxy and sulfonyl derivatives; imidazotetrazolopyrimidines and intermediates |
| 01/15/2004 | US20040009995 Treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade |
| 01/15/2004 | US20040009981 Oxazole, thiazole, 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives of pyrimidines, 1,2,4- and 1,3,5-triazines |
| 01/15/2004 | US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 01/15/2004 | US20040009974 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles |
| 01/15/2004 | US20040009968 Indazole compounds useful as protein kinase inhibitors |
| 01/15/2004 | US20040009942 Administering a polynucleotide having an immunostimulatory sequence comprising the sequence 5'-C, G-3'; a respiratory virus antigen is not administered |
| 01/15/2004 | US20040009941 Microspheres and adjuvants for DNA vaccine delivery |
| 01/15/2004 | US20040009930 Macrolide antibiotics |
| 01/15/2004 | US20040009928 Isolation from a new marine microbe, strain PO13-046, belonging to the genus Actinomadura sp. |
| 01/15/2004 | US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |
| 01/15/2004 | US20040009897 Stabilized synthetic immunogen delivery system |
| 01/15/2004 | US20040009603 Antiviral vectors |
| 01/15/2004 | US20040009551 Comprises nucleotide sequences coding peptide antibiotic for treatment of parasitic infection and cell proliferative disorders |
| 01/15/2004 | US20040009546 Compositions and methods for inhibiting microbial adhesion |
| 01/15/2004 | US20040009244 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 01/15/2004 | US20040009228 Bioabsorbable drug delivery system for local treatment and prevention of infections |
| 01/15/2004 | US20040009193 Lipid bilayer membrane derived from a eukaryotic microorganism as an outer membrane |
| 01/15/2004 | US20040009191 Inactivated virulence genes |
| 01/15/2004 | US20040009187 Rotavirus subunit vaccine |
| 01/15/2004 | US20040009184 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 01/15/2004 | US20040009183 Recombinant DNA construct comprising a vector and at least one nucleic acid fragment comprising any combination of proteins selected from the group consisting of mSEA and mSEB; food poisoning |
| 01/15/2004 | US20040009179 Mycoplasma gallisepticum formulation |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009126 Inhalation system for prevention and treatment of intracellular infections |
| 01/15/2004 | DE10228059A1 Verwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen Infektionskrankheiten Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases |
| 01/15/2004 | DE10227938A1 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 01/15/2004 | DE10227914A1 Pharmazeutische Zubereitung mit retardierender Wirkstofffreisetzung, Verfahren zu ihrer Herstellung und Verwendung Pharmaceutical formulation having retarded active substance release, methods for their preparation and use |
| 01/15/2004 | CA2767092A1 Novel compounds, pharmaceutical compositions containing same and methods of use for same |
| 01/15/2004 | CA2494508A1 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | CA2492035A1 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/15/2004 | CA2492010A1 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | CA2491607A1 Plant peptide with antimicrobial activity |
| 01/15/2004 | CA2491573A1 Methods of treating microbial infections in humans and animals |
| 01/15/2004 | CA2491508A1 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | CA2491464A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 01/15/2004 | CA2491074A1 O-derivatized nocathiacin derivatives |
| 01/15/2004 | CA2491011A1 Cationic linear peptides having antibacterial and/or antifungal properties |
| 01/15/2004 | CA2490708A1 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |